Category Archives: Utah’s Life Sciences Companies
UNIVERSITY OF UTAH, ARUP, AND TECHCYTE DEVELOP NANOSPOT.AI, A NEW ULTRA-FAST TEST FOR COVID-19 ANTIBODIES
The University of Utah (the U), ARUP Laboratories, and Techcyte Inc. announced that they have formed a partnership to develop NanoSpot.AI, a less than five-minute, easy-to-administer COVID-19 antibody test. NanoSpot.AI is estimated to be significantly less expensive to manufacture than other antibody tests, so it has the potential to be much more affordable and extend […]
PhotoPharmics Innovations Address Global Health Inequalities
PhotoPharmics has announced its intent to leverage its FDA breakthrough device designation, potential streamlined Medicare coverage under CMS’ pending Medicare Coverage of Innovative Technology (MCIT) rule and global delivery channels to deliver its treatments for Parkinson’s and neurodegenerative diseases to individuals regardless of their location or income. Innovation not only brings improved treatments to address […]
SDP Oncology Presents New Data from Investigational Pipeline of Novel Cancer Therapeutics at AACR Virtual Annual Meeting I 2021
Lehi-based Sumitomo Dainippon Pharma Oncology (SDP Oncology) recently presented new findings on a range of investigational agents from the company’s pipeline at the American Association for Cancer Research (AACR) Virtual Annual Meeting I. The data presented at the meeting include preclinical and Phase 1 clinical data evaluating the potential anti-cancer activity of the PKM2 activator […]
Innovative Med Tech Startup Xenter Announces Company Launch
Xenter has announced its formal launch in Salt Lake City. Founded in 2020 by seasoned life sciences entrepreneur Richard J. Linder, Xenter is innovating new wireless technologies and techniques for the treatment of heart and vascular disease. The company’s next-generation devices will integrate functions that formerly required multiple costly devices. “We are bringing the world’s […]
Utah’s Recursion Goes Public – Announces Pricing of IPO
Recursion Pharmaceuticals, Inc. today announced the pricing of its initial public offering of its Class A common stock at a price to the public of $18.00 per share. Recursion is offering 24,242,424 shares of its Class A common stock. The gross proceeds from the offering are expected to be $436.4 million. The shares are expected to […]
IONIQ Sciences Announces Dr. Raphael E. Pollock Has Joined Its Medical Advisory Committee
IONIQ Sciences, Inc. recently announced that Raphael E. Pollock, MD, PhD, FACS has joined its Medical Advisory Committee. Dr. Pollock is an award-winning surgical oncologist, extensively published physician- scientist, Professor Emeritus in the Department of Surgical Oncology at MD Anderson Cancer Center and currently the Director of The Ohio State University Comprehensive Cancer Center (OSUCCC). […]
FDA Permits Marketing of BioFire COVID-19 Diagnostic Test Using Traditional Premarket Review Process
On March 17, the FDA granted marketing authorization of the BioFire Respiratory Panel 2.1 (RP2.1), a diagnostic test for the simultaneous qualitative detection and identification of multiple respiratory viral and bacterial nucleic acids in nasopharyngeal swabs (NPS) obtained from individuals suspected of COVID-19 and other respiratory tract infections. The diagnostic test, which had an Emergency […]
Utah’s Biomerics Announces Expansion of Texas, Costa Rica Operations
Biomerics, headquartered in Salt Lake City, and a leading mid-market medical device contract manufacturer, has announced it is expanding its manufacturing footprint in Athens, TX where Biomerics FMI is a vertically integrated high volume catheter development and manufacturing leader in the attractive PTA, Endourology, and Endoscopy markets. The Texas expansion totals 24,000 sq. ft. including […]
IONIQ Sciences Finalist in National ‘Buzz of BIO’ Awards
Utah’s own IONIQ Sciences was named a finalist for the prestigious ‘Buzz of BIO 2021’ award in the ‘Diagnostic and Beyond’ category. Although IONIQ did not win the category, being among the top finalists is a signiicant distinction. Placement was determined by companies receiving the most votes. “We’re on a mission to modernize cancer detection […]
Co-Diagnostics, Inc. Partner to Offer At-Home Saliva Collection Kits for CoPrimer™-Based COVID-19 PCR Test Through Walgreens Find Care®
Co-Diagnostics has announced that laboratory partner Clinical Reference Laboratory’s (CRL) FDA-authorized Rapid Response COVID-19 Saliva Test, which uses Co-Diagnostics CoPrimer™ technology, is now available through Walgreens Find Care®, allowing consumers a convenient, non-invasive option for PCR-based COVID-19 testing from their own. Dwight Egan, Co-Diagnostics CEO, stated, “Co-Diagnostics is proud that our technology will be available […]
The University of Utah and RenalytixAI Partner to Drive Innovation in Kidney Health
Utah’s RenalytixAI and the University of Utah last week announced a partnership to improve kidney health and reduce the risk of kidney failure for large scale populations in the earliest stages of kidney disease. The partnership intends to implement RenalytixAI’s in vitro diagnostic platform, KidneyIntelX, in combination with a range of advanced clinical management solutions […]
American Society of Nephrology and Renalytix Co-Host Virtual Capital Markets Day for Kidney Health
RenalytixAI co-hosted a Capital Markets Day for Kidney Health with the American Society of Nephrology yesterday, Feb. 11. The virtual event brought together a broad group of delegates representing the kidney community, including leading clinicians, representatives of U.S. government health agencies, kidney care innovators and investors focused on life sciences and medical technology, for a […]
